Levy, Jonathan M. http://orcid.org/0000-0002-8061-7953
Yeh, Wei-Hsi http://orcid.org/0000-0001-7507-8177
Pendse, Nachiket
Davis, Jessie R.
Hennessey, Erin
Butcher, Rossano
Koblan, Luke W.
Comander, Jason
Liu, Qin
Liu, David R. http://orcid.org/0000-0002-9943-7557
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01 AI142756, RM1 HG009490, R01 EB022376, R35 GM118062)
Article History
Received: 20 June 2019
Accepted: 4 December 2019
First Online: 14 January 2020
Competing interests
: D.R.L. is a consultant and co-founder of Beam Therapeutics, Prime Medicine, Editas Medicine and Pairwise Plants, all of which are companies that use genome editing. D.R.L., J.M.L., W.-H.Y. and L.W.K. have filed patent applications on AAV systems for base editor delivery. The remaining authors declare no competing interests.